期刊
CURRENT OSTEOPOROSIS REPORTS
卷 10, 期 1, 页码 48-55出版社
SPRINGER
DOI: 10.1007/s11914-011-0083-y
关键词
Secondary osteoporosis; Transplantation; Immunosuppressive agents; Bone loss
资金
- Novartis
- Abbott
- Amgen
Transplantation is an established therapy for end-stage diseases of kidney, lung, liver, and heart among others. Osteoporosis and fragility fractures are serious complications of organ transplantation, particularly in the first post-transplant year. Many factors contribute to the pathogenesis of osteoporosis following organ transplantation. This review addresses the mechanisms of bone loss that occurs both in the early and late post-transplant periods, including the contribution of the immunosuppressive agents as well as the specific features to bone loss after kidney, lung, liver, cardiac, and bone marrow transplantation. Prevention and treatment for osteoporosis in the transplant recipient are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据